Ardelyx Inc. (United States) is listed on the Nasdaq and has a market capitalization of $745.02 million, with shareholders equity totaling $164.05 million.
The company employs approximately 489 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Ardelyx Inc. reported $468.22 million in revenue, generating net income of $-55.47 million.
Key financial metrics include a P/E ratio of -13.43, a price-to-book (P/B) ratio of 4.54, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ARDX.